Download video

Dr. Nada El-Garhy SOH IPD2024 Case Presentation

25 views

SOH MK

13 days ago

Dr. Nada El-Garhy SOH IPD2024 Case Presentation

Dr. Nada El-Garhy SOH IPD2024 Case Presentation

Dr. Nada El-Garhy SOH IPD2024 Case Presentation
11:16
Dr. Nada El-Garhy SOH IPD2024 Case Presentation
by SOH MK
Clinical applications of liquid biopsy in metastatic breast cancer
1:17
Clinical applications of liquid biopsy in metastatic breast cancer
by VJOncology
Evaluating the safety of T-DXd with radiotherapy in HER2+ metastatic breast cancer
0:48
Evaluating the safety of T-DXd with radiotherapy in HER2+ metastatic breast cancer
by VJOncology
8-kan Arrin Iska Ilali Xiliga Caadada !
4:06
8-kan Arrin Iska Ilali Xiliga Caadada !
by Dr Sadam Hussein
Immunotherapy for Advanced Prostate Cancer with Neal Shore, MD- EP 103
55:35
Immunotherapy for Advanced Prostate Cancer with Neal Shore, MD- EP 103
by Dr. Geo Prostate Podcast
Docteur Seth Mukadi _ Nehuschtan_2Rois 18:4
30:01
Docteur Seth Mukadi _ Nehuschtan_2Rois 18:4
by Docteur Seth Mukadi
Gastrointestinal cancer trials to watch out for in 2023
0:35
Gastrointestinal cancer trials to watch out for in 2023
by VJOncology
Controversies in the treatment of the axilla
0:28
Controversies in the treatment of the axilla
by VJOncology
Transform from Fat to Fit | Dr. Nada
1:49
Transform from Fat to Fit | Dr. Nada
by MedCentres
Next steps in anti-amyloid immunotherapy
1:46
Next steps in anti-amyloid immunotherapy
by VJDementia
Decoy-resistant IL-18 plus anti-CTLA-4 blockade for renal cell carcinoma
1:24
Decoy-resistant IL-18 plus anti-CTLA-4 blockade for renal cell carcinoma
by VJOncology
Potential for liquid biopsies in colorectal cancer
0:42
Potential for liquid biopsies in colorectal cancer
by VJOncology
TALAPRO-2: exploratory analyses of HRR gene subgroups in mCRPC
1:19
TALAPRO-2: exploratory analyses of HRR gene subgroups in mCRPC
by VJOncology
Treatment ovarian cancer with novel targeted therapies and IO
3:56
Treatment ovarian cancer with novel targeted therapies and IO
by VJOncology
Safety \& efficacy of T-DXd with chemotherapy \& immunotherapy in gastric cancer
0:36
Safety \& efficacy of T-DXd with chemotherapy \& immunotherapy in gastric cancer
by VJOncology
NADIM: baseline ctDNA as a prognostic factor for PFS
1:21
NADIM: baseline ctDNA as a prognostic factor for PFS
by VJOncology
AZD7789 in NSCLC: safety, efficacy, and ongoing evaluation
2:38
AZD7789 in NSCLC: safety, efficacy, and ongoing evaluation
by VJOncology
Recognizing the need to improve ovarian cancer cure rates
2:39
Recognizing the need to improve ovarian cancer cure rates
by VJOncology
Drs. Fizazi, Wallis on Updated Data from TALAPRO-2
11:19
Drs. Fizazi, Wallis on Updated Data from TALAPRO-2
by GU Oncology Now
Copy of Dr. Sonpavde on Key Data With Immunotherapy in Metastatic Bladder Cancer
0:47
Copy of Dr. Sonpavde on Key Data With Immunotherapy in Metastatic Bladder Cancer
by OncLive